報告人：施暢
時間：2022年12月13日 下午13:30
騰訊會議號：624 477 816
會議密碼：258963
【報告人簡介】
施暢，上海對外經(jīng)貿(mào)大學金融管理學院講師，金融學博士，2022年6月畢業(yè)于香港城市大學經(jīng)濟金融系。主要研究領域為實證公司金融，包括企業(yè)人力資本、企業(yè)創(chuàng)新、M&As等領域。曾受邀參加2022 Asian Finance Association Annual Meeting , 2022 Financial Markets and Corporate Governance等金融學領域國際會議并報告論文。
【內(nèi)容摘要】
This paper examines the impact of the local opioid epidemic on corporate innovation. Using a large sample of U.S. public firms from 2003 to 2017, we find that firms located in counties with higher death rates caused by opioid overdoses are significantly less innovative as measured by their patenting activities. To establish causality, we exploit the state implementations of the Prescription Drug Monitoring Programs (PDMPs) as quasi-experiments and an instrumented variable approach. We find suggestive evidence that the opioid epidemic hinders local firms’ innovation by increasing their healthcare costs, decreasing their productivity, and by causing an exodus of local inventors.
【主持人簡介】
應尚軍，教授，資產(chǎn)評估師，上海對外經(jīng)貿(mào)大學金融管理學院副院長、資產(chǎn)評估研究所所長、碩士生導師。兼任全國資產(chǎn)評估教育研究會共同會長、中國優(yōu)選法統(tǒng)籌法與經(jīng)濟數(shù)學研究會能源經(jīng)濟與管理研究分會常務理事、上海市金融學會理事、上海市金融碩士教學指導委員會成員、上海市國資系統(tǒng)資產(chǎn)評估評審專家。
